没有数据	没有数据

没有数据	没有数据

来源	SDS样本
没有数据	没有数据

产品合成路线

更多

名称	CAS号

更多

文章

同行评议文献

Formation of electrochemically reduced graphene oxide on melamine electrografted layers and its application toward the determination of methylxanthines.Srinivasan Kesavan et al.Analytical biochemistry, 496, 14-24 (2016-01-01) Isolation and initial characterization of a series of Chlamydia trachomatis isolates selected for hydroxyurea resistance by a stepwise procedure.G Tipples et al.Journal of bacteriology, 173(16), 4932-4940 (1991-08-01) N-carbamoyloxyurea-resistant Chinese hamster ovary cells with elevated levels of ribonucleotide reductase activity.R G Hards et al.Journal of cellular physiology, 106(2), 309-319 (1981-02-01) [Pharmacokinetics of antitumor drugs].V A Filov et al.Voprosy onkologii, 29(7), 3-13 (1983-01-01) Current investigational drugs of interest in the Chemotherapy Program of the National Cancer Institute.S K Carter et al.National Cancer Institute monograph, (45)(45), 101-121 (1977-03-01) Naked eye and spectrophotometric detection of chromogenic insecticide in aquaculture using amine functionalized gold nanoparticles in the presence of major interferents.C Loganathan et al.Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy, 173, 837-842 (2016-11-07) Studies on the selective toxicity of guanazole in mice.C Dave et al.European journal of cancer, 14(1), 33-40 (1978-01-01) Inhibition of ribonucleotide reductases encoded by herpes simplex viruses.T Spector Pharmacology & therapeutics, 31(3), 295-302 (1985-01-01) Measurements of ionization constants and partition coefficients of quanazole prodrugs.A A Alhaider et al.Journal of pharmaceutical sciences, 71(1), 89-94 (1982-01-01) Molecular structure and vibrational study of diprotonated guanazolium using DFT calculations and FT-IR and FT-Raman spectroscopies.L Guennoun et al.Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy, 97, 975-985 (2012-08-29) Alternative bases in the RNA world: the prebiotic synthesis of urazole and its ribosides.V M Kolb et al.Journal of molecular evolution, 38, 549-557 (1994-01-01) Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.Lourdes Santana et al.Journal of medicinal chemistry, 51(21), 6740-6751 (2008-10-07) Molecular geometry and vibrational studies of 3,5-diamino-1,2,4-triazole using quantum chemical calculations and FT-IR and FT-Raman spectroscopies.L Guennoun et al.Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy, 78(1), 347-353 (2010-11-30) Ribonucleotide reductase from wild type and hydroxyurea-resistant chinese hamster ovary cells.W H Lewis et al.Journal of cellular physiology, 97(1), 87-97 (1978-10-01) Schedule-dependency assessments of ribonucleoside diphosphate reductase inhibitors when used in combination with platinum compounds plus cyclophosphamide in the treatment of advanced L1210 leukemia.G R Gale et al.Cancer treatment reports, 63(3), 449-456 (1979-03-01) Studies on the differential mechanisms of inhibition of ribonucleotide reductase by specific inhibitors of the non-heme iron subunit.A Sato et al.Advances in enzyme regulation, 22, 231-241 (1984-01-01) DNA repair induced by various mutagens in rat hepatocyte primary cultures measured in the presence of hydroxyurea, guanazole or aphidicolin.W Suter et al.Mutation research, 231(2), 251-264 (1990-08-01) Studies of mammalian ribonucleotide reductase activity in intact permeabilized cells: a genetic approach.J A Wright et al.Advances in enzyme regulation, 19, 105-127 (1980-01-01) Herpes simplex type 1 ribonucleotide reductase. Mechanism studies with inhibitors.T Spector et al.The Journal of biological chemistry, 260(15), 8694-8697 (1985-07-25) Drug-induced loss of unstably amplified genes.M A Wani et al.Cancer investigation, 8(6), 587-593 (1990-01-01) Guanazole in the treatment of advanced bronchogenic carcinoma: a pilot study of the Southeastern Cancer Study Group.S Krauss et al.Cancer treatment reports, 70(7), 913-914 (1986-07-01) Effect of iron-chelating agents on inhibitors of ribonucleotide reductase.J G Cory et al.Biochemical pharmacology, 30(9), 979-984 (1981-05-01) Specific inhibition of the subunits of ribonucleotide reductase as a new approach to combination chemotherapy.J G Cory et al.Advances in enzyme regulation, 19, 139-150 (1980-01-01) Characterization of the active site of ribonucleotide reductase of Escherichia coli, bacteriophage T4 and mammalian cells by inhibition studies with hydroxyurea analogues.I K Larsen et al.European journal of biochemistry, 125(1), 75-81 (1982-06-15) The inhibition of ribonucleoside diphosphate reductase by hydroxyurea, guanazole and pyrazoloimidazole (IMPY).E C Moore et al.Pharmacology & therapeutics, 27(2), 167-196 (1985-01-01) Evolution of bacterial genomes.J T Trevors Antonie van Leeuwenhoek, 71(3), 265-270 (1997-03-01) A series of N-carbamoyloxyurea resistant cell lines with alterations in ribonucleotide reductase: lack of coordination in pyrimidine and purine reductase activity.R G Hards et al.Canadian journal of biochemistry and cell biology = Revue canadienne de biochimie et biologie cellulaire, 61(2-3), 120-129 (1983-02-01) Synthesis and evaluation of guanazole prodrugs as antineoplastic agents.C Dias Selassie et al.Journal of pharmaceutical sciences, 70(11), 1281-1283 (1981-11-01)

备注